Psychedelic News
Psychedelic Business News Spotlight: April 9, 2021
This week in psychedelic business news: a psilocybin delivery system for brain inflammation, a genetic test to predict your psychedelic-assisted therapy experience, and a potential first treatment for a debilitating form of schizophrenia.
Psychedelic Business News Spotlight: April 9, 2021
This week in psychedelic business news: a psilocybin delivery system for brain inflammation, a genetic test to predict your psychedelic-assisted therapy experience, and a potential first treatment for a debilitating form of schizophrenia.
Psychedelic Conference to Explore Promising Therapies for Veterans, First Responders
The Heroic Dose conference will explore the use of psychedelic therapies to treat post-traumatic stress disorder, substance abuse, and suicide among military veterans and first responders.
Interview With Dr. Joseph Tucker
MagicMed Industries’ CEO, Dr. Joseph Tucker, talks about their psychedelic library, the company’s plans to go public and what the future of psychedelic research looks like.
California Moves Closer to Decriminalizing Psychedelics
With 2 cities in the Golden State already decriminalizing psychedelics, could the rest of California be next?
The Company of Others: How Shared Psychedelic Experiences Influence Outcomes
Does taking psychedelics with others improve the experiences for all individuals? Researchers are looking at the benefits.
The Company of Others: How Shared Psychedelic Experiences Influence Outcomes
Does taking psychedelics with others improve the experiences for all individuals? Researchers are looking at the benefits.